Jeffs' Brands Says SciSparc Nutraceuticals Was Granted an Exclusive License For Sales Of CannAmide On Amazon Marketplace In Canada
Portfolio Pulse from Benzinga Newsdesk
Jeffs' Brands announced that SciSparc Nutraceuticals has been granted an exclusive license for sales of CannAmide on Amazon Marketplace in Canada.
June 07, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amazon will host the sales of CannAmide by SciSparc Nutraceuticals on its Canadian Marketplace.
While the exclusive license for sales of CannAmide on Amazon Marketplace in Canada is a positive development for SciSparc Nutraceuticals, it is unlikely to have a significant short-term impact on Amazon's stock price, as it is just one of many products available on the platform.
CONFIDENCE 80
IMPORTANCE 20
RELEVANCE 50
POSITIVE IMPACT
Jeffs' Brands announced the exclusive license for SciSparc Nutraceuticals to sell CannAmide on Amazon Marketplace in Canada.
The announcement of the exclusive license for SciSparc Nutraceuticals to sell CannAmide on Amazon Marketplace in Canada is a positive development for Jeffs' Brands, as it could lead to increased sales and revenue for the company in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
SciSparc Nutraceuticals was granted an exclusive license for sales of CannAmide on Amazon Marketplace in Canada by Jeffs' Brands.
The exclusive license for sales of CannAmide on Amazon Marketplace in Canada is a positive development for SciSparc Nutraceuticals, as it could lead to increased sales and revenue for the company in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100